epidoxorubicin ( edx ) was administered to a group of 26 patients with acute leukaemia or lymphoma , replacing either daunorubicin or doxorubicin ( dxr ) as a component of multiple-chemotherapy regimens .
C0011015
daunorubicin
C0013089
doxorubicin